ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

ACADIA Pharmaceuticals, Inc. 

3911 Sorrento Valley Boulevard

San Diego  California  92121   U.S.A.
Phone: 858-558-2871 Fax: 858-558-2872


SEARCH JOBS



Segment
Drug Discovery

Collaborations

Allergan Inc.  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

Allergan Inc.  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

Allergan Inc.  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.

Sunovion Pharmaceuticals Inc.  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.





 Company News
ACADIA Pharmaceuticals, Inc. (ACAD) To Present At The 13th Annual Needham Healthcare Conference On April 8, 2014 4/1/2014 7:56:06 AM    More...
ACADIA Pharmaceuticals, Inc. (ACAD) Prices Public Offering Of Common Stock 3/5/2014 9:37:22 AM    More...
ACADIA Pharmaceuticals, Inc. (ACAD) To Present At Upcoming Investor Conferences 3/5/2014 7:34:41 AM    More...
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2013 2/28/2014 7:09:55 AM    More...
ACADIA Pharmaceuticals, Inc. (ACAD) To Announce Fourth Quarter And Full Year 2013 Financial Results On February 27, 2014 2/20/2014 7:25:29 AM    More...
ACADIA Pharmaceuticals, Inc. (ACAD) To Present At Upcoming Investor Conferences 11/26/2013 7:08:36 AM    More...
ACADIA Pharmaceuticals, Inc. (ACAD)s Announces Initiation Of Phase 2 Trial With Pimavanserin For Alzheimer’s Disease Psychosis 11/14/2013 9:27:20 AM    More...
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Third Quarter 2013 Financial Results 11/7/2013 7:59:41 AM    More...
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Publication in The Lancet of Pivotal Phase III Parkinson's Disease Psychosis Trial With Pimavanserin 11/1/2013 10:54:50 AM    More...
ACADIA Pharmaceuticals, Inc. (ACAD) to Announce Third Quarter 2013 Financial Results on November 6, 2013 10/30/2013 7:23:53 AM    More...
12345678910...